Insider · CIK 0001423786
Francis Willard Sarena
cooofficer
Files at ETNB (89bio, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 30, 2025 | ETNB 89bio, Inc. | UTender of shares Common Stock | -75,310 | - | - | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -350,000 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -215,000 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Aug 1, 2025 | ETNB 89bio, Inc. | FTax withholding Common Stock | -3,206 | $9.16 | $29k | 77,210 | Aug 5, 2025 |
| Aug 5, 2025 | ETNB 89bio, Inc. | FTax withholding Common Stock | -2,979 | $9.69 | $29k | 74,231 | Aug 5, 2025 |
| Feb 1, 2025 | ETNB 89bio, Inc. | AGrant or award Common Stock | +53,750 | $0.00 | $0 | 78,750 | Feb 4, 2025 |
| Feb 1, 2025 | ETNB 89bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +215,000 | $0.00 | $0 | 215,000 | Feb 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.